Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Devos

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Molecular Microbiology|October 27, 2001
A la carte transcriptional regulators: unlocking responses of the prokaryotic enhancer-binding protein XylR to non-natural effectorsJ Garmendia, D Devos, A Valencia, et al.
Environmental Microbiology|April 23, 2002
Deciphering the action of aromatic effectors on the prokaryotic enhancer-binding protein XylR: a structural model of its N-terminal domainD Devos, J Garmendia, V de Lorenzo, et al.
Ejhaem|October 17, 2024
Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirineMehdi Hamadani, Melanie Lucero, Jakob D DeVos, et al.
Revue Neurologique|May 27, 2015
Clinical implications of neuropharmacogeneticsJ-C Corvol, D Devos, J-S Hulot, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 1, 1988
Long-term relationship between weight and aerobic-fitness change in childrenL H Epstein, R R Wing, A Valoski, et al.
Annales D'Endocrinologie|December 17, 2005
[Hypogonadotropic hypogonadism discovered in a patient with cerebellar ataxia]G Robin, S Jonard, I Vuillaume, et al.
Pharmacological Research|March 7, 2012
Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's diseaseC Laloux, M Petrault, C Lecointe, et al.
Developmental Pharmacology and Therapeutics|January 1, 1984
The need for pharmacokinetic monitoring of gentamicin therapy in critically ill neonatesM Kalenga, D Devos, D Moulin, et al.
Panminerva Medica|March 12, 2013
Management of ischemic stroke in the hyperacute phaseD Devos, M Sevin, S De Gaalon, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 29, 2000
[Thulium laser evoked potentials. Normative values for the arms and legs]D Devos, C Creac'h, E Laureau, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Molecular Microbiology|October 27, 2001
A la carte transcriptional regulators: unlocking responses of the prokaryotic enhancer-binding protein XylR to non-natural effectorsJ Garmendia, D Devos, A Valencia, et al.
Environmental Microbiology|April 23, 2002
Deciphering the action of aromatic effectors on the prokaryotic enhancer-binding protein XylR: a structural model of its N-terminal domainD Devos, J Garmendia, V de Lorenzo, et al.
Ejhaem|October 17, 2024
Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirineMehdi Hamadani, Melanie Lucero, Jakob D DeVos, et al.
Revue Neurologique|May 27, 2015
Clinical implications of neuropharmacogeneticsJ-C Corvol, D Devos, J-S Hulot, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 1, 1988
Long-term relationship between weight and aerobic-fitness change in childrenL H Epstein, R R Wing, A Valoski, et al.
Annales D'Endocrinologie|December 17, 2005
[Hypogonadotropic hypogonadism discovered in a patient with cerebellar ataxia]G Robin, S Jonard, I Vuillaume, et al.
Pharmacological Research|March 7, 2012
Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's diseaseC Laloux, M Petrault, C Lecointe, et al.
Developmental Pharmacology and Therapeutics|January 1, 1984
The need for pharmacokinetic monitoring of gentamicin therapy in critically ill neonatesM Kalenga, D Devos, D Moulin, et al.
Panminerva Medica|March 12, 2013
Management of ischemic stroke in the hyperacute phaseD Devos, M Sevin, S De Gaalon, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 29, 2000
[Thulium laser evoked potentials. Normative values for the arms and legs]D Devos, C Creac'h, E Laureau, et al.
Pageof 11